Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Handling Material Return Post Dispensing – V 2.0

Posted on By

Elixir Department: SOP for Handling Material Return Post Dispensing – V 2.0

Standard Operating Procedure for Handling Return of Materials after Dispensing in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/036/2025
Supersedes SOP/ELX/036/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

This SOP outlines the procedure for managing returned materials after partial dispensing during elixir manufacturing. It ensures proper handling, identification, storage, and documentation of returned raw materials to maintain their quality and traceability.

2. Scope

This SOP applies to all returned raw materials, excipients, and solvents that remain unused after dispensing operations in the Elixir Department and are returned to the warehouse or storage area.

3. Responsibilities

  • Dispensing Operator:
    • Return unused material immediately after dispensing with intact labeling and seals.
  • Warehouse Staff:
    • Verify the return condition and quantity, and reassign proper storage location.
  • QA Personnel:
    • Inspect and approve return for reuse or recommend rejection.
    • Maintain return records and ensure traceability.
See also  Elixir Department: SOP for Use of Barcode Systems During Dispensing - V 2.0

4. Accountability

The Warehouse In-Charge is accountable for ensuring that returned materials are handled as per this SOP and comply with GMP and traceability requirements.

5. Procedure

5.1 Immediate Return after Dispensing

  1. After completing dispensing, the operator shall seal the remaining material using its original closure system.
  2. Label the container with a “Returned Material” tag, including:
    • Material Name
    • Batch Number
    • Returned Quantity
    • Date
    • Dispensing Reference Number
  3. Submit the material along with the filled Material Return Slip to the warehouse.

5.2 Warehouse Verification

  1. Warehouse personnel shall:
    • Verify physical integrity of the container and seal.
    • Cross-check quantity returned with the dispensing logbook.
    • Confirm labeling and accompanying documentation.
  2. Reject the material if there are signs of tampering, contamination, or labeling discrepancies.

5.3 Quality Assurance Review

  1. QA shall:
    • Inspect the condition of the returned material.
    • Determine if the material is reusable based on visual and documented review.
    • Approve or reject the material by signing the Return Slip and recording the decision.
See also  Elixir Department: SOP for Dispensing Under Laminar Airflow Cabinet - V 2.0

5.4 Storage and Status Update

  1. Store approved returned material in its original storage conditions with proper identification label (e.g., “Partially Used – Approved”).
  2. Update the inventory control system with the returned quantity and status.
  3. Rejected materials should be moved to the “Rejected Area” and documented in the Non-Conformance Register.

5.5 Documentation

  1. Record details of returned materials in the Material Return Register (Annexure-1).
  2. Attach a copy of the Certificate of Analysis (CoA) if required by QA (Annexure-2).
  3. Maintain the Return Approval Form signed by QA (Annexure-3).

6. Abbreviations

  • QA: Quality Assurance
  • CoA: Certificate of Analysis
  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice

7. Documents

  1. Material Return Register (Annexure-1)
  2. Certificate of Analysis (Annexure-2)
  3. Return Approval Form (Annexure-3)

8. References

  • 21 CFR Part 211 – Good Manufacturing Practices for Finished Pharmaceuticals
  • WHO TRS 986 Annex 2 – GMP Guidelines for Pharmaceutical Products
See also  Elixir Department: SOP for Double Check System During Material Dispensing - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Material Return Register

Date Material Batch No. Qty Returned Returned By Condition QA Status
11/04/2025 Sodium Saccharin SS9911 0.300 kg Rajesh Kumar Intact Approved

Annexure-2: Certificate of Analysis (CoA)

Material Batch No. Test Result Complies
Sodium Saccharin SS9911 Assay 100.1% Yes

Annexure-3: Return Approval Form

Date Material Batch No. Returned By Reviewed By (QA) Disposition
11/04/2025 Sodium Saccharin SS9911 Rajesh Kumar Sunita Reddy Reusable – Approved

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Version Document Creation QA Head
11/04/2025 2.0 Included Return Labeling and Disposition Flow Audit Recommendation QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Creams: SOP for Water Activity Measurement in Cream Formulations – V 2.0
Next Post: API Manufacturing: SOP for Use of Conductivity Meter in API Plant – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version